17 Ken Griffin Orchard Therapeutics plc - ADR Trades
The first Orchard Therapeutics plc - ADR trade was made in Q3 2019.
Since then Ken Griffin bought shares six more times and sold shares on ten occasions. The investor completely sold their stake between Q3 2023 and Q4 2023.
Avg closing price
Price range
Sold -95.3 Thousand shares
Q4 2023
Avg closing price
$15.75
Price range
$8.14
-
$16.47
Sold 24.1% shares (-30.2 Thousand shares)
Q3 2023
Avg closing price
$5.42
Price range
$4.83
-
$8.21
Increased shares by 1.8% (+2.21 Thousand shares)
Q2 2023
Avg closing price
$5.10
Price range
$4.68
-
$5.83
Sold 46.3% shares (-106 Thousand shares)
Q1 2023
Avg closing price
$5.44
Price range
$4.40
-
$6.57
Increased shares by 0.2% (+397 shares)
Q4 2022
Avg closing price
$4.42
Price range
$3.65
-
$5.15
Increased shares by 10602.5% (+227 Thousand shares)
Q3 2022
Avg closing price
$5.57
Price range
$4.53
-
$6.94
Sold 85.9% shares (-13 Thousand shares)
Q2 2022
Avg closing price
$5.64
Price range
$4.22
-
$7.80
Sold 20.1% shares (-3.81 Thousand shares)
Q1 2022
Avg closing price
$9.80
Price range
$7.00
-
$15.10
Sold 3.0% shares (-582 shares)
Q4 2021
Avg closing price
$16.54
Price range
$11.60
-
$22.30
Sold 26.5% shares (-7.02 Thousand shares)
Q3 2021
Avg closing price
$29.75
Price range
$22.40
-
$42.90
Sold 17.2% shares (-5.52 Thousand shares)
Q2 2021
Avg closing price
$55.71
Price range
$43.90
-
$72.30
Increased shares by 1547.0% (+30.1 Thousand shares)
Q1 2021
Avg closing price
$71.03
Price range
$43.90
-
$90.80
Sold 98.6% shares (-133 Thousand shares)
Q3 2020
Avg closing price
$51.69
Price range
$41.10
-
$64.50
Increased shares by 56.4% (+48.8 Thousand shares)
Q2 2020
Avg closing price
$91.61
Price range
$57.50
-
$119.90
Increased shares by 71.0% (+35.9 Thousand shares)
Q1 2020